Back to Search

P3 Efficacy Evaluation of Enobosarm in Combo With Abemaciclib Compared to Estrogen Blocking Agent for 2nd Line Treatment of ER+HER2- MBC in Patients Who Have Shown Previous Disease Progression on an Estrogen Blocking Agent Plus Palbociclib

  • Protocol Number: 202209170
  • Principal Investigator: Ademuyiwa, Foluso
  • Cancer Types: Breast

For more information on this trial, contact us here:

[email protected]

Brief Summary

Protocol Interventions